The $345 central target is the average of 12 recent, individually attributed analyst price targets, rounded from a calculated mean near $344. The targets reviewed include Citi at $440 (Buy, Nov. 6), CMB International at $380 (Buy, Nov. 6), J.P. Morgan at $385 (Buy, Nov. 5), Rosenblatt at $400 (Buy, Nov. 5), Needham at $340 (Buy, Nov. 5), Morgan Stanley at $325 (Hold, Nov. 6), Craig-Hallum at $310 (Buy, Nov. 5), BofA at $240 (Hold, Nov. 5), B. Riley at $262 (Neutral, Oct. 30), StoneX at $425 (Buy, Oct. 26), Susquehanna at $350 (Oct. 21), and TD Cowen at $275 (Oct. 19).
The resulting range of roughly $240 to $440 is unusually wide, signaling genuine divergence. Bullish firms emphasize accelerating optical transceiver and datacenter demand tied to AI buildouts. More cautious analysts, including BofA's Vivek Arya and Morgan Stanley, flag valuation, margin, and cash-flow constraints. Recent weeks brought a wave of target reductions — BofA cut to $240 from $400, Craig-Hallum to $310 from $480, and Rosenblatt to $400 from $500 — while Citi moved in the opposite direction, raising its target to $440. The mean is a statistical midpoint, not a guarantee or an official published consensus.
At a recent close of $192.81, Coherent sits roughly 56% below its 52-week high of $440 and near the middle of a 52-week range spanning $130.42 to $440.00. Reaching $345 would require an advance of approximately 79%, a very large move that would still leave the stock below its prior peak.
The path would depend on sustained execution against an aggressive growth plan. Coherent's fiscal first-quarter 2027 revenue rose 50% year over year to $2.37 billion, and management guided to more than 60% pro forma revenue growth for the full fiscal year. Even so, the shares carry a P/E (price-to-earnings ratio) near 40 times trailing earnings and trade below both their 20-day and 50-day moving averages, meaning a meaningful recovery would need to be led by fundamentals and renewed investor confidence rather than a single catalyst.
Coherent is a leading provider of lasers, optical transceivers, and engineered materials positioned squarely in the AI infrastructure supply chain. Demand for high-speed optical connectivity in datacenters underpins the bull case. Analysts have highlighted a reported five-year PhotonLink supply agreement with a hyperscaler valued near $20 billion, which could support multi-year revenue visibility. Management's guidance for more than 60% pro forma revenue growth in fiscal 2027, combined with a forward earnings multiple below its five-year average, gives bulls room to argue the stock remains attractively priced relative to its growth trajectory.
The principal obstacle is cash conversion. Coherent reported negative operating cash flow in the September quarter while spending roughly $776 million on capital expenditures and building inventory to $3.3 billion. Its non-GAAP gross margin near 40.6% trails some optical peers, and a beta near 2.8 makes the shares far more volatile than the broader market. Because the story depends heavily on continued hyperscaler spending, any slowdown in AI capital expenditure, margin disappointment, or valuation compression could keep the stock well below $345. Insider selling activity has also been cited by some as a near-term caution flag.
Near-term support sits around $177 to $185, with resistance clustered near $198 and again around $205. More durable overhead levels include the 50-day moving average near $260 and, ultimately, the 52-week high of $440, which represents the market's prior peak valuation of the AI-optics growth story. The stock's position below its intermediate-term moving averages indicates the longer-term trend remains under repair.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual assumptions vary widely. The next major test is the fiscal second-quarter report expected in early February, when operating cash flow, inventory levels, and gross margins will show whether the company's higher spending is translating into profitable sales. Investors should also watch hyperscaler capex commentary, any additional revisions to analyst targets, and interest-rate policy, which influences valuations of high-multiple growth stocks.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single static view, the system helps traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently as conditions evolve. For those tracking volatile names such as Coherent, incorporating an AI-driven signal alongside fundamental research can add a useful layer of discipline to the decision-making process.
The $345 target represents the average of 12 current analyst price targets and implies roughly 79% upside from a recent price near $192.81 — a very large move. Support rests on exceptional AI-optics demand, a major hyperscaler agreement, and aggressive revenue-growth guidance, while the principal obstacles are weak cash generation, heavy capital spending, margin pressure, and elevated volatility. The wide $240-to-$440 target range underscores genuine analyst disagreement about how to value that growth. Whether Coherent approaches $345 will likely hinge on the February earnings report, cash-flow improvement, and the durability of AI infrastructure spending.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, COHR has been closely correlated with MKSI. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if COHR jumps, then MKSI could also see price increases.
| Ticker / NAME | Correlation To COHR | 1D Price Change % | ||
|---|---|---|---|---|
| COHR | 100% | -4.68% | ||
| MKSI - COHR | 76% Closely correlated | +0.89% | ||
| KEYS - COHR | 67% Closely correlated | +0.86% | ||
| VPG - COHR | 53% Loosely correlated | +1.29% | ||
| ST - COHR | 52% Loosely correlated | -0.40% | ||
| ESE - COHR | 46% Loosely correlated | -0.92% | ||
More | ||||